Search

everythinglearnresearchcommunity

for

Search:↓

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Targeting specific cell interactions may help treat skin fibrosis.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Different wool coat types in goats are linked to specific gene expressions, which could improve cashmere quality.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Blue light therapy is promising for skin and hair conditions but needs more research for widespread use.

Targeted immune modulation can help achieve stable remission in alopecia areata.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Belimumab may cause hair loss in lupus patients.

Natural products might be safe, effective, and affordable treatments for hair loss.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

The method effectively mimics shaving damage on skin for testing skincare products.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional liposuction for cell therapy.

COVID-19 reinfection may trigger alopecia areata.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

New treatments for sudden hair loss include oral medications and a special laser, both showing promise in hair regrowth.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

COVID-19 may cause temporary hair loss due to the body's immune response.

COVID-19 may cause hair loss months after infection.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.